CEA-Leti is carrying out the first clinical trials in humans of an intracerebral device which emits a neuro-protecting light aims to slow down neurodegeneration. Unlike other treatments for Parkinson’s, which are only symptomatic, photobiomodulation has been demonstrated to slow down the disease in rodent and non-human primates.​
